Close

Publications

Vekemans, J; SCHELLENBERG, D; Benns, S; O'Brien, K; Alonso, P;
2021
Vaccine, (2021).39 22 10.1016/j.vaccine.2021.03.093.
How can the public health impact of vaccination be estimated?.
Echeverria-Londono, S; Li, X; Toor, J; De Villiers, MJ; Nayagam, S; Hallett, TB; Abbas, K; Jit, M; KLEPAC, P; Jean, K; Garske, T; Ferguson, NM; Gaythorpe, KA M;
2021
BMC public health, (2021).21 1
Stuurman, AL; Sharan, A; Jahagirdar, S; Elango, V; Riera-Montes, M; Kashyap, N; Biccler, J; Poluru, R; Arora, N; Mathai, M; MANGTANI, P; DeVlieger, H; Anderson, S; Whitaker, B; Wong, H-L; Cutland, C; Guillard Maure, C; WHO GVS MCC Sites,;
2021
Vaccine: X, (2021).9, 10.1016/j.jvacx.2021.100123.
Lancet Commission on COVID-19 Vaccines and Therape,;
2021
The Lancet. Global health, (2021).9 7 10.1016/S2214-109X(21)00140-6.
Du, F; CHANTLER, T; Francis, MR; Sun, FY; Zhang, X; Han, K; Rodewald, L; Yu, H; Tu, S; LARSON, H; Hou, Z;
2021
Vaccines, (2021).9 3 10.3390/vaccines9030201.
Kalam, MA; Davis, TP; Shano, S; Uddin, MN; Islam, MA; Kanwagi, R; Islam, A; Hassan, MM; LARSON, HJ;
2021
PloS one, (2021).16 8 10.1371/journal.pone.0256496.
Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
Fu, H; Abbas, K; KLEPAC, P; VAN ZANDVOORT, K; Tanvir, H; Portnoy, A; Jit, M;
2021
BMC medicine, (2021).19 1
THE R21/MATRIX-M (TM) MALARIA VACCINE CANDIDATE: A PHASE III TRIAL.
Datoo, MS; Natama, HM; Lopez, FR; Some, A; Traore, O; Rouamba, T; Roberts, R; Weston, S; Stockdale, L; Bellamy, D; Williams, N; Lawrie, A; Sorgho, H; Hamaluba, M; Olotu, A; Ouedraogo, J-B; Dicko, A; GREENWOOD, B; Chandramohan, D; Bejon, P; CAIRNS, M; Glenn, G; Reimer, J; Shaligram, U; Shaligram, U; ... Hill, AV.
2021
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2021).105 5